Matching placebo for tezepelumab solution for injection

DRUG2 trials

Sponsors

AstraZeneca AB, Centre Hospitalier Universitaire De Montpellier

Conditions

Severe Uncontrolled Asthma Asthma (an illness that causes breathing difficulty) that is not fully controlledSevere asthmaso that asthma attacks are still occurring despite the use of other available treatments

Phase 3

A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children with Severe Uncontrolled Asthma (HORIZON)

RecruitingCTIS2022-502984-39-00

AstraZeneca ABSevere Uncontrolled Asthma Asthma (an illness that causes breathing difficulty) that is not fully controlled, so that asthma attacks are still occurring despite the use of other available treatments

Start: 2023-12-13Target: 45Updated: 2025-12-03

REVERT : REVErsing airway Remodelling with Tezepelumab : a protocol for a double blind randomized controlled trial for patients with asthma

RecruitingCTIS2024-513195-18-00

Centre Hospitalier Universitaire De MontpellierSevere asthma

Start: 2023-03-27Target: 150Updated: 2025-02-20